Parse Biosciences Invalidates All 10x Genomics’ Patent Claims Asserted Against Its Products

Contributed by: Business Wire

Logo

Tags

Stem Cells

Medical Supplies

Biotechnology

Professional Services

Health

Patent Law

Pharmaceutical

Oncology

Research

Genetics

Science

Parse Biosciences

More Like This

Parse Launches GigaLab to Scale Single Cell Sequencing to Billions of Cells Annually

Parse Biosciences Acquires Biomage

Parse Biosciences Launches 5 Million Cell Evercode WT Penta Kit for Single Cell Sequencing

Parse Biosciences Quadruples Sample Multiplexing Abilities for Evercode WT Mega Kits

Parse Biosciences Launches Evercode Whole Transcriptome Version 3, Boosting Usability and Performance

Parse Biosciences Launches Laboratory Automation Provider Program, Collaborates with Hamilton, Opentrons Labworks, SPT Labtech

Parse Biosciences Closes $50 Million of Financing to Fuel Continued Worldwide Growth

Parse Biosciences Partners with Taiwan-based Prisma Biotech to Extend Reach in Asia